Recent advances in vaccine and immunotherapy for COVID-19
- Ali A. Rabaan(corresponding author),
- Shamsah H. Al-Ahmed,
- Ranjit Sah,
- Jaffar A. Al-Tawfiq,
- Ayman M. Al-Qaaneh,
- Lamiaa H. Al-Jamea
- Johns Hopkins Aramco Healthcare,
- Qatif Central Hospital,
- Tribhuvan University Teaching Hospital,
- Indiana University School of Medicine,
- Johns Hopkins University School of Medicine,
- Imam Abdulrahman Bin Faisal university
Research Output:
Contribution to journal
Article
Peer-review
Open access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Peer-reviewOriginal language
EnglishPages from-to (Number of pages)
Pages 3011-3022 (12 pages)Journal (Volume, Issue Number)
Human Vaccines and Immunotherapeutics (Volume 16, Issue 12)Publication milestones
- Published - 2020
Publication status
Published - 2020
ISSN
2164-5515Publication IDs
- Scopus: 85095809734
- PubMed: 33156739
Abstract
The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.
Publication metrics
Metrics
Sustainable Development Goals
SDG 3 Good Health and Well